Kemmeren J - Search Results

1

Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.

Kemmeren J, Honsbeek M, Dijkstra F, de Lange M, van der Maas N, Smallenburg R, Koppeschaar C, van der Hoek W. Kemmeren J, et al. Vaccine. 2016 Jul 25;34(34):3961-6. doi: 10.1016/j.vaccine.2016.06.055. Epub 2016 Jun 24. Vaccine. 2016. PMID: 27349839

2

Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands.

Bults M, Kemmeren JM, van der Maas NA. Bults M, et al. Among authors: kemmeren jm. Vaccine. 2007 Jul 20;25(29):5272-7. doi: 10.1016/j.vaccine.2007.05.017. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17573165

3

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE. van der Maas NA, et al. Among authors: kemmeren jm. Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7. Ned Tijdschr Geneeskd. 2007. PMID: 18225797 Dutch.

4

Discolored leg syndrome after vaccination--descriptive epidemiology.

Kemmeren JM, Vermeer-de Bondt PE, van der Maas NA. Kemmeren JM, et al. Eur J Pediatr. 2009 Jan;168(1):43-50. doi: 10.1007/s00431-008-0707-0. Epub 2008 Jun 11. Eur J Pediatr. 2009. PMID: 18546020

5

Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection.

van der Maas NA, Bondt PE, de Melker H, Kemmeren JM. van der Maas NA, et al. Among authors: kemmeren jm. Vaccine. 2009 Mar 18;27(13):1970-3. doi: 10.1016/j.vaccine.2009.01.019. Epub 2009 Jan 30. Vaccine. 2009. PMID: 19186201

6

[Safety of the bivalent human papillomavirus vaccine--results following administration of more than 192,000 doses].

van der Maas NA, Kemmeren JM, de Melker HE. van der Maas NA, et al. Ned Tijdschr Geneeskd. 2009;153:A964. Ned Tijdschr Geneeskd. 2009. PMID: 19930738 Dutch.

7

Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children.

Kemmeren JM, van der Maas NA, de Melker HE. Kemmeren JM, et al. Eur J Pediatr. 2011 Mar;170(3):339-45. doi: 10.1007/s00431-010-1294-4. Epub 2010 Sep 21. Eur J Pediatr. 2011. PMID: 20857144

8

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children.

Kemmeren JM, Timmer SS, van der Maas NA, de Melker HE. Kemmeren JM, et al. Vaccine. 2011 Jun 10;29(26):4373-7. doi: 10.1016/j.vaccine.2011.04.009. Epub 2011 Apr 22. Vaccine. 2011. PMID: 21514347

9

Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.

van Klooster TM, Kemmeren JM, van der Maas NA, de Melker HE. van Klooster TM, et al. Among authors: kemmeren jm. Vaccine. 2011 Jun 20;29(28):4601-7. doi: 10.1016/j.vaccine.2011.04.050. Epub 2011 May 5. Vaccine. 2011. PMID: 21549785

10

Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.

van't Klooster TM, Kemmeren JM, de Melker HE, Vermeer-de Bondt PE, van der Maas NA. van't Klooster TM, et al. Hum Vaccin. 2011 Oct;7(10):1048-54. doi: 10.4161/hv.7.10.16692. Epub 2011 Oct 1. Hum Vaccin. 2011. PMID: 21957494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters